Allarity Therapeutics, Inc. ( ALLR) - Key Metrics
ALLR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.21 | -$0.16 | -$0.16 |
| 2026Q1 | $0 | -$0.17 | -$0.28 | -$0.29 |
| 2025Q4 | $0.02 | -$0.23 | -$0.23 | -$0.23 |
| 2025Q3 | $0 | -$0.19 | -$0.23 | -$0.23 |
| 2025Q2 | $0 | -$0.15 | -$0.35 | -$0.35 |
ALLR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.54 |
| 2026Q1 | 0% | -1.60 |
| 2025Q4 | 0% | -1.29 |
| 2025Q3 | 0% | -2.08 |
| 2025Q2 | 0% | -1.68 |
ALLR
Price: $1
52 week price:
Earnings Per Share: -0.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 959260
Market Capitalization: 15.8 million